Table 1.
Clinical and epidemiological details of the analysed patients with primary central nervous system lymphoma (PCNSL) and neurosarcoidosis (NS).
| Age (yrs) | Gender | Location | Immuno-compromised | Contrast | |
|---|---|---|---|---|---|
| PCNSL | |||||
| P1 | 82.6 | F | R temporal | N | MH |
| P2 | 63.6 | M | R middle cerebral peduncle | N | GV |
| P3 | 66 | F | Bil-parietal lobes [R > L] | N | GV |
| P4 | 44.6 | M | Multiple periventricular | N | GV |
| P5 | 67.2 | F | L frontal | N | MH |
| Neurosarcoidosis | |||||
| P1 | 35.2 | F | R parietal | N | MH |
| P2 | 32 | M | Hypothalamus & L temporal | N | GV |
| P3 | 28.7 | M | N | GV | |
| L1 | 28.7 | M | R basal ganglia | N | GV |
| L2 | L basal ganglia | GV | L basal ganglia | GV | |
| L3 | Midbrain | GV | Mid brain | GV | |
| P4 | 55.4 | F | L frontal | N | GV |
F: female; M: male; N: normal; GV: gadavist; L: left; MH: multihance; R: right.